ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
Source: SeekingAlpha
2026-02-04 13:32:33 ET
More on related tickers
- Trane Technologies: Upgrade To Buy On Cheaper Valuation And Better Fundamentals
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Linde Q4 2025 Earnings Preview
- Genentech in up to $1.7B RNAi licensing deal with SanegeneBio
Read the full article on Seeking Alpha
For further details see:
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
Zai Lab Limited
NASDAQ: ZLAB
ZLAB Trading
-2.58% G/L:
$18.587 Last:
115,166 Volume:
$18.86 Open:
ZLAB Latest News
February 26, 2026 07:00:00 am
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
ZLAB Stock Data
$2,174,273,322
105,108,310
0.9%
39
N/A
Biotechnology & Life Sciences
Healthcare
CN
Shanghai
